⏰ Last chance! Join Premium for $20/month before it increases to $49/month.

Enlivex Therapeutics Ltd. Ordinary Shares

$0.2064
-0.0184 (-8.19%)

Volume:

476.349K ($97.96K)

Market Capitalization:

$3.61M

Live Price

Live Volume

Chart Volume 0
Volume 0
5 sec

Enlivex Therapeutics Market Segments

Overnight

*No Trades in Segment

After Hours

+0.0014(+0.68%)
Open$0.2050
Close$0.2064
Low$0.2000
Low Change-0.0050 (-2.44%)
High$0.2132
High Change+0.0082 (+4.00%)
Range$0.0132
Volume29.548K
Dollar Volume$6.10K

Regular Trading Hours

-0.0253(-10.99%)
Open$0.2303
Close$0.2050
Low$0.2045
Low Change-0.0258 (-11.20%)
High$0.2334
High Change+0.0031 (+1.35%)
Range$0.0289
Volume435.621K
Dollar Volume$89.30K

Premarket

-0.0045(-1.93%)
Open$0.2334
Close$0.2289
Low$0.2200
Low Change-0.0134 (-5.74%)
High$0.2335
High Change+0.0001 (+0.04%)
Range$0.0135
Volume11.18K
Dollar Volume$2.56K

After Hours Yesterday

-0.0021(-0.94%)
Open$0.2242
Close$0.2221
Low$0.2221
Low Change-0.0021 (-0.94%)
High$0.2354
High Change+0.0112 (+5.00%)
Range$0.0133
Volume13.123K
Dollar Volume$2.91K

Regular Trading Hours Yesterday

+0.0046(+2.09%)
Open$0.2202
Close$0.2248
Low$0.2100
Low Change-0.0102 (-4.63%)
High$0.2358
High Change+0.0156 (+7.08%)
Range$0.0258
Volume421.183K
Dollar Volume$94.68K

Premarket Yesterday

+0.0002(+0.09%)
Open$0.2162
Close$0.2164
Low$0.2156
Low Change-0.0006 (-0.28%)
High$0.2298
High Change+0.0136 (+6.29%)
Range$0.0142
Volume39.43K
Dollar Volume$8.53K

Enlivex Therapeutics News

There is no current news for this stock at the moment.

Enlivex Therapeutics Top Trades

Enlivex Therapeutics's top trade so far today returned +6.09%, while the top short trade returned -14.35%.

Enlivex Therapeutics Moving Averages

5 Day Moving Average (SMA5)$0.2349
10 Day Moving Average (SMA10)$0.2852
20 Day Moving Average (SMA20)$0.4379
50 Day Moving Average (SMA50)$1.0087
100 Day Moving Average (SMA100)$1.5392
200 Day Moving Average (SMA200)$1.2537

Enlivex Therapeutics Statistics

Average Volume (30 Days)1.74M
P/E Ratio (Current)-.60
EPS (Current)-$0.42
Dividend Yield0.00%
Free Cash Flow—
Cash Ratio1.30
Current Ratio8.72
Quick Ratio8.72
Debt to Equity0.00
Enterprise Value-$695.85K
EV to EBITDA0.07
EV to Sales—
Price to Book0.14
Price to Cash Flow—
Price to Free Cash Flow—
Price to Sales—
Return on Assets-0.21%
Return on Equity-0.24%

Enlivex Therapeutics Stock Splits

There have been 3 stock splits for Enlivex Therapeutics (ENLV). The last reverse stock split occured on July 9, 2026 and reduced the outstanding shares at a ratio of 15:1.

DateTypeRatio
Jul 9, 2026Reverse15:1
Mar 6, 2019Reverse8:1
Sep 25, 2017Reverse5:1

Enlivex Therapeutics Dividends

There have been no dividends for Enlivex Therapeutics (ENLV).